Maravai Lifesciences Holdings MRVI
NASDAQ MRVI
$7.32 -0.05 (-0.68%)
At close: Sep 4, 2026 · 4:00 PM EDT

Maravai Lifesciences Holdings (MRVI) Other Working Capital Changes (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) posted quarterly Other Working Capital Changes of -$203000.0 for Q1 2026, up 97.61% year-over-year from -$102728.1 in Q1 2025, and up 89.28% quarter-over-quarter from -$1.9 million in Q4 2025.

Analysis

Maravai Lifesciences Holdings (MRVI) Other Working Capital Changes (2020 - 2025) Analysis & Trends

Maravai Lifesciences Holdings' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$203000.0 for Q1 2026.

  • In Q1 2026, Other Working Capital Changes rose 97.61% year-over-year to -$203000.0; the TTM figure through Mar 2026 stood at -$10.3 million (up 24.16% YoY), while the FY2025 annual figure was -$18.6 million, down 195.78% from the prior year.
  • Other Working Capital Changes for Q1 2026 stood at -$203000.0, up from -$1.9 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $26.3 million in Q3 2022, with the low at -$21.3 million in Q2 2023.
  • The 5-year median for Other Working Capital Changes is -$439000.0 (2024), against an average of $2.0 million.
  • Peak annual rise in Other Working Capital Changes reached 12217.19% in 2025, while the deepest fall reached 638.26% in 2025.
  • Maravai Lifesciences Holdings' Other Working Capital Changes stood at -$2.7 million in 2022, then soared by 40.04% to -$1.6 million in 2023, then increased by 29.88% to -$1.2 million in 2024, then tumbled by 64.61% to -$1.9 million in 2025, then surged by 89.28% to -$203000.0 in 2026.
  • Business Quant data shows MRVI's Other Working Capital Changes at -$203000.0 in Q1 2026, -$1.9 million in Q4 2025, and -$16.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Maravai Lifesciences Holdings 1.09 Bn 1.02 Bn 20.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1.12 Mn
Jun 30, 2025 -1.12 Mn
Mar 31, 2025 381,000.00
Mar 31, 2025 381,000.00
Dec 31, 2024 472,000.00
Dec 31, 2024 472,000.00
Sep 30, 2024 -244,000.00
Sep 30, 2024 -244,000.00
Jun 30, 2024 -64,000.00
Jun 30, 2024 -64,000.00
Mar 31, 2024 -1.15 Mn
Mar 31, 2024 -1.15 Mn
Dec 31, 2023 808,000.00
Dec 31, 2023 808,000.00
Sep 30, 2023 94,000.00
Sep 30, 2023 94,000.00
Jun 30, 2023 406,000.00
Jun 30, 2023 406,000.00
Mar 31, 2023 -1.06 Mn
Mar 31, 2023 -1.06 Mn